G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $236,000 | -55.2% | 20,495 | -5.8% | 0.00% | -100.0% |
| Q2 2020 | $527,000 | +34.8% | 21,754 | -38.7% | 0.00% | 0.0% |
| Q1 2020 | $391,000 | -71.2% | 35,494 | -30.8% | 0.00% | 0.0% |
| Q4 2019 | $1,356,000 | -19.5% | 51,303 | -24.6% | 0.00% | -50.0% |
| Q3 2019 | $1,684,000 | +9.3% | 68,013 | +35.3% | 0.00% | +100.0% |
| Q2 2019 | $1,541,000 | +162.1% | 50,272 | +42.0% | 0.00% | 0.0% |
| Q1 2019 | $588,000 | +130.6% | 35,406 | +165.8% | 0.00% | – |
| Q4 2018 | $255,000 | – | 13,323 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 856,798 | $6,512,000 | 1.75% |
| CHI Advisors LLC | 488,635 | $3,714,000 | 1.58% |
| Pinz Capital Management, LP | 186,515 | $1,418,000 | 0.88% |
| Lombard Odier Asset Management (Switzerland) SA | 542,183 | $4,121,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 316,137 | $2,403,000 | 0.24% |
| Birchview Capital, LP | 40,000 | $304,000 | 0.22% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 160,000 | $1,216,000 | 0.18% |
| Tekla Capital Management LLC | 423,869 | $3,221,000 | 0.11% |
| Golden Green, Inc. | 12,152 | $92,000 | 0.08% |
| Virtus ETF Advisers LLC | 15,188 | $115,000 | 0.05% |